Faculty Directory

Maskiewicz, V.K., Williams, P.A., Prates, S.J., Bowsher, J.G., and Clarke, I.C., "Characterization of Proteins in Serum-Based Lubricants During Simulation Wear Testing of Metal-on-Metal Hip Prostheses", submitted to Journal of Biomedical Materials Research: Part B - Applied Biomaterials,94, 429-440, 2010

( 10/2010 - 10/2012 )

US Patent 7,074,763 - "Stable Formulations of Nerve Growth Factor", V.M. Knepp ( 9/2007 - 9/2009 )

US Patent 6,730,328 - "Stable Protein and Nucleic Acid Formulations Using Non-Aqueous, Anhydrous, Aprotic, Hydrophobic, Non-Polar Vehicles with Low Reactivity", Maskiewicz, V.K., Prestrelski, S.J., Smith, J.G., and Huang, M.T. ( 9/2004 - 9/2009 )

US Patent 6,277, 828 - "Pharmaceutical Formulations of Nerve Growth Factor", Maskiewicz, V.K., Lidgate, D., Maskiewicz, R. ( 9/2001 - 9/2009 )

US Patent 6,264,990 - "Stable Protein and Nucleic Acid Formulations Using Non-Aqueous, Anhydrous, Aprotic, Hydrophobic, Non-Polar Vehicles with Low Reactivity", Maskiewicz, V.K., Prestrelski, S.J., Smith, J.G., and Huang, M.T. ( 9/2000 - 9/2009 )

Knepp, V.M., Muchnik, A., Oldmark, S, and Kalashnikova,L., "Stability of Non-Aqueous Suspension Formulations of Plasma Derived Factor IX and Recombinant Human Alpha-Interferon at Elevated Temperatures", Pharm. Res., 15(7), 1090-1095 ( 9/1998 - 9/2009 )

V.M. Knepp, J.L. Whatley, A. Muchnik, and T.S. Calderwood, “Identification of Antioxidants for Prevention of Peroxide Mediated Oxidation of Recombinant Human Ciliary Neurotrophic Factor and Recombinant Human Nerve Growth Factor,” J. Pharm. Sci and Technol., 50 (3), 163 - 171, 1996. ( 9/1996 - 9/2009 )

G.C. Visor, K.P. Tsai, M.D. Miller, J. Duffy, T.S. Calderwood, D.Lokensgard, J. Killian, T. Malefyt, L. Gu, I. Massey, and V. M. Knepp, “Development and Characterization of a Lyophilized Dosage Form of IL-1ß”, Lymphokine Res., 9, (3), 425 - 434, 1990. ( 9/1990 - 9/2009 )

G.C.Visor, K.P. Tsai, J. Duffy, M.D. Miller, T.S. Calderwood. and V.M. Knepp, “Quantitative Evaluation of the Stability and Delivery of Interleukin-1ß by Infusion”, J. Parenteral Sci. and Technol., 44 (3), 130 - 132, 1990,. ( 9/1990 - 9/2009 )

V.M. Knepp, F.C. Szoka, and R.H. Guy, “Controlled Drug Release from a Novel Liposomal Drug Delivery System. II. Transdermal Delivery Characteristics”, J. Control. Rel., 12, 25 - 30, 1990. ( 9/1990 - 9/2009 )

V.M. Knepp, and R.H. Guy, “Transport of Steroids at Model Biomembrane Surfaces and across Organic Liquid - Aqueous Phase Interfaces”, J. Phys. Chem., 93 (18), 6817 - 6823, 1989. ( 9/1989 - 9/2009 )

V.M. Knepp, J. Hadgraft,, and R.H.Guy, “Transdermal Drug Delivery: Problems and Possibilities”, CRC Crit. Rev. Ther. Drug Carrier Syst., 4 (1), 13-37 1987. ( 9/1987 - 9/2009 )

V.M. Knepp, R.S. Hinz, F.C. Szoka, and R.H. Guy, “A New Liposomal Delivery System for Controlled Drug Release,” Controlled Release Technology Pharmaceutical Applications, ACS Symposium Series 348, P.I. Lee and W.R. Good, Eds.,Washington DC, 267-272, 1987. ( 9/1987 - 9/2009 )

V.M. Knepp, “Sulfonamide Diuretics”, Drug Level Monitoring, Volume 2, W.S. Sadee and E.T. Lin, Eds., John Wiley and Sons, New York, 356-377, 1985. ( 9/1985 - 9/2009 )

Perry, C.C., Sabir, T.S., Livingston, W.J., Milligan, J.R., Chen, Q., Maskiewicz, V.M. and Boskovic, D.S., “Fluorescence of commercial Pluronic F127 samples: Temperature-dependent micellization”, Journal of Colloid and Interfacial Science, 354(2), 662-229, 2011 ( 1/2011 - Present )

Scholarly Journals--Submitted

( 9/2009 )